Canada Orbital Atherectomy Market Size & Outlook, 2026-2034
Canada Orbital Atherectomy Market Insights
- Reed Intelligence analysis indicates that the Canada Orbital Atherectomy Market size, valued at USD 67.93 Million in 2025, is expected to expand to USD 155.26 Million by 2034.
- The Canada market is forecasted to expand at a CAGR of 9.62% spanning 2026–2034.
- Coronary Artery Disease held the leading position among Application segments in 2025, based on market size.
- Coronary Artery Disease is projected to post the fastest growth rate, sustaining its position as the most attractive Application segment during the forecast horizon.
![Canada Orbital Atherectomy Market Size, Share & Growth Report By [2034]](https://reedintelligence.com/uploads/charts/canada-orbital-atherectomy-market-canada-application-96071.png)
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- As of 2025, Canada held 6.47% of the global Orbital Atherectomy Market size.
- By 2034, United States is anticipated to capture the largest share of the global Orbital Atherectomy Market.
- In North America, United States is expected to lead the regional Orbital Atherectomy Market size by 2034.
- Canada will remain the fastest-growing market in North America, reaching USD 155.26 Million by 2034.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 67.93 Million |
| Market Size In 2034 | USD 155.26 Million |
| Largest segment | Coronary Artery Disease |
| Units | Revenue in USD Million |
| CAGR | 9.62% (2026-2034) |
| Segmnetation Covered | |
| Application |
|
| Product Type |
|
| End-Use |
|
| End-User Specialty |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Canada Orbital Atherectomy Market Application 2026-2034 (USD Million)
| Application | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Coronary Artery Disease | XX.x | XX.x | XX.x | 38.76 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Peripheral Artery Disease | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
Canada Orbital Atherectomy Market Product Type 2026-2034 (USD Million)
| Product Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Orbital Atherectomy Systems | XX.x | XX.x | XX.x | 43.86 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Accessories Consumables | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
Canada Orbital Atherectomy Market End-Use 2026-2034 (USD Million)
| End-Use | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | XX.x | XX.x | XX.x | 34.08 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Ambulatory Surgical Centers | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Specialty Clinics | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
Canada Orbital Atherectomy Market End-User Specialty 2026-2034 (USD Million)
| End-User Specialty | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interventional Cardiology | XX.x | XX.x | XX.x | 38.95 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Vascular Surgery | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
